UBS AM
KYMR icon

UBS AM’s Kymera Therapeutics KYMR Stock Holding History

UBS AM’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$73M Sell
875,872
-36,626
-4% -$2.9M 0.02% 560
2025
Q4 		$71M Buy
912,498
+48,736
+6% +$3.29M 0.02% 549
2025
Q3 		$48.9M Buy
863,762
+44,835
+5% +$2.02M 0.01% 604
2025
Q2 		$35.7M Sell
818,927
-77,477
-9% -$2.67M 0.01% 809
2025
Q1 		$24.5M Buy
896,404
+491,737
+122% +$17.9M 0.01% 879
2024
Q4 		$16.3M Sell
404,667
-23,862
-6% -$1.08M ﹤0.01% 1042
2024
Q3 		$20.3M Sell
428,529
-5,044
-1% -$223K 0.01% 945
2024
Q2 		$12.9M Buy
433,573
+253,635
+141% +$8.78M ﹤0.01% 1031
2024
Q1 		$7.23M Buy
179,938
+3,438
+2% +$123K ﹤0.01% 1116
2023
Q4 		$4.49M Sell
176,500
-13,233
-7% -$237K ﹤0.01% 1296
2023
Q3 		$2.64M Buy
189,733
+13,205
+7% +$265K ﹤0.01% 1485
2023
Q2 		$5.23M Hold
176,528
– – ﹤0.01% 1202
2023
Q1 		$5.23M Sell
176,528
-3,039
-2% -$98K ﹤0.01% 1202
2022
Q4 		$4.48M Buy
179,567
+12,022
+7% +$321K ﹤0.01% 1205
2022
Q3 		$3.65M Sell
167,545
-26,779
-14% -$706K ﹤0.01% 1316
2022
Q2 		$3.83M Sell
194,324
-235,919
-55% -$5.51M ﹤0.01% 1314
2022
Q1 		$18.2M Buy
430,243
+164,192
+62% +$6.93M 0.01% 867
2021
Q4 		$16.9M Sell
266,051
-238
-0.1% -$13.9K 0.01% 948
2021
Q3 		$15.6M Sell
266,289
-15,750
-6% -$913K 0.01% 936
2021
Q2 		$13.7M Buy
+282,039
New +$12.2M 0.01% 999

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return